The latest Crohn's News articles published daily. Includes news on Crohn's Disease (CD) an inflammatory disorder of the intestinal tract. Current research, symptoms and treatment options.
ChemoCentryx Reports Positive PROTECT-1 Study Results For Traficet-EN(TM) At The GASTRO 2009 UEGW/WCOG Conference
26 November 2009
ChemoCentryx, Inc., announced that Phase II/III clinical data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with...
[
read article]
Thalidomide: Solving The 50-Year-Old Puzzle
18 November 2009
Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues...
[
read article]
Subset Data From Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates Of Hospitalization In Patients With Crohn's Disease
28 October 2009
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with...
[
read article]
For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to: